Page History
Completed by: | |
Date Completed: | 26 Mar 2021 |
Name and Version of Project: |
|
...
BEFORE POSTING FOR PUBLIC REVIEW
- in-line comments need addressing - Done
All internal review comments have been resolved and updated in JIRA.- Supplement has been through copy-editing.
- This will be moved to copy-editing after comments are addressed. The FDA priority list has been checked to see if the supplement is marked "yes".
- Not an FDA priority
- . This will need to go through copy-editing and then to the FDA for review (if they still want to review this version). If the supplement is an FDA priority, it has gone through FDA review and additional copy-editing if there were extensive changes
- The FDA disclaimer is in the supplement if they reviewed it and not in the supplement if it's not an FDA priority.
- Notify the SDS QRS Subteam that the supplements are ready for public review.
- Announcement has been prepared.
- Project Manager/Team Lead notified Ann White (Communications) at least 5 days before planned public review posting so she can review the announcement and post to the CDISC website.
...
Overview
Content Tools